Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 16,201

Document Document Title
WO/2024/146619A1
The present invention relates to an aurone derivative or analog as represented by formula (I), and a preparation method therefor, a pharmaceutical composition thereof and the use thereof. The aurone derivative or analog can be used as an...  
WO/2024/147287A1
The present invention provides: an active light sensitive or radiation sensitive resin composition with which a pattern having excellent resolution can be formed; a resist film; a pattern forming method; and a method for producing an ele...  
WO/2024/147149A1
The present invention discloses a process for preparing high purity 3-chlorothiophene. The said process comprises the steps of: (a) contacting an impure mixture comprising 3-chlorothiophene with a metal catalyst in the presence of hydrog...  
WO/2024/141543A1
The invention concerns a compound of formula (I): the process for the preparation thereof and the use thereof as photoinitiator, preferably as photoinitiator activable under 350-460 nm light irradiation, notably to cure formulations comp...  
WO/2024/142976A1
This composition contains a compound represented by formula (1) and a curable compound. In formula (1), PM+ is a cation represented by formula (PM1), and A- is an anion represented by formula (AN1). The present invention pertains to a fi...  
WO/2024/143131A1
The purpose of the present invention is to provide: an actinic ray-sensitive or radiation-sensitive resin composition which has excellent LWR performance and enables the reduction of residues after development; a resist film, a pattern f...  
WO/2024/142966A1
The problem addressed is: to provide a polymer mechanoradical initiator obtained by mechanochemical treatment of an organic polymer material as a radical initiator for reactions in which the polymer mechanoradical initiator component is ...  
WO/2024/130411A1
Inhibitors of the SARS-CoV-2 Mpro protease and methods of their use in treating a coronavirus infection in a subject are provided. The inhibitors may have the general structure (I) :  
WO/2024/131772A1
The present application relates to a compound having a STING inhibitory effect and a pharmaceutical composition thereof, and use thereof in the preparation of a medicament for preventing and/or treating diseases related to abnormal STING...  
WO/2024/128017A1
Provided is a new sulfonium salt that, when being irradiated with light beams having an ultrashort wavelength, quickly degrades and generates an acid. This sulfonium salt is represented by formula (1). In formula (1), R1 represents an ...  
WO/2024/127977A1
The present invention uses a resist composition containing: a base material component of which the solubility in a developer solution changes due to the action of an acid; and a compound represented by general formula (d0). In the formul...  
WO/2024/126674A1
The present invention relates to a process for the preparation of relugolix or a pharmaceutically salt thereof. It also relates to new intermediates and their use for the preparation of relugolix.  
WO/2024/122345A1
The present invention addresses the problem of providing a method for producing a homo-coupling reaction product, whereby it becomes possible to substantially eliminate the use of an organic solvent, to carry out a reaction under a mild ...  
WO/2024/122301A1
The present invention provides a photoelectric conversion element that demonstrates excellent quantum efficiency when receiving blue light. The present invention also provides an imaging device, a photosensor, and a compound that relate ...  
WO/2024/124043A1
Compounds of Formula (I) are derivatives of salvinorin A. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions a disease or disorder that can be treated wit...  
WO/2024/120149A1
The present invention relates to the technical field of liquid crystal materials, and in particular to a dibenzothiophene liquid crystal compound, and a preparation method therefor and a use thereof. The present invention provides a dibe...  
WO/2024/120471A1
The present invention provides compounds of formula (I) which can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. Also provided are pharmaceutical ...  
WO/2024/116207A1
Provided herein are compounds identified as inhibitors of ADAR1 activity, such as compounds having the formula: (I) or (II), or a pharmaceutically acceptable salt or tautomer thereof, that are useful in treating cancer and other disorder...  
WO/2024/119131A1
A spiro-thiophene compound includes a centroid core having a plurality of benzene rings, and a plurality of thiophene molecules covalently bonded to a carbon atom of the plurality of benzene rings of the centroid core to form a centroid-...  
WO/2024/117003A1
Provided is a compound represented by formula (1).  
WO/2024/116780A1
The present invention provides: a resist composition that is improved in terms of a decrease in roughness and sensitivity, and that can suppress film reduction during development; a resist pattern formation method that uses the resist co...  
WO/2024/117761A1
The present specification relates to a compound of formula 1 and an organic light-emitting element comprising same.  
WO/2024/117265A1
The present invention relates to binaphthyl compounds of the formula {I) that are suitable as monomers for preparing thermoplastic resins, such as polycarbonate resins, which have beneficial optical and mechanical properties and can be u...  
WO/2024/114085A1
The present invention provides a triarylamine organic functional compound and a use thereof. The compound has a structure as represented by formula (I). The (A) group has a dibenzo five-membered ring or six-membered ring structure. The p...  
WO/2024/110680A1
The present invention relates to thiophene derivatives and to the use of these compounds of formula (I) to prevent and/or treat viral diseases. More particularly, the invention relates to the use of these compounds to treat and/or preven...  
WO/2024/108179A2
Pharmaceutically active 2-ethylamine substituted benzofuran and benzothiophene compositions are provided for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also incl...  
WO/2024/101044A1
Provided are a resist composition in which the temporal stability during storage is increased and a decrease in fine resolution after storage is reduced, a resist pattern formation method using said resist composition, and a compound use...  
WO/2024/099518A1
The invention relates to salts and complexes with 3-acetal-4-hydroxybicyclo[3.3.1]non-3-ene-2,9-dione derivatives. According to the invention, the derivatives comprise a compound of the general formula (IA) or (IB), wherein A represents ...  
WO/2024/097831A1
Provided herein are, inter alia, unnatural amino acids, proteins comprising unnatural amino acids, biomolecule conjugates, and methods of making the unnatural amino acids, proteins, and biomolecule conjugates. In embodiments, the unnatur...  
WO/2024/095734A1
This fluorine-containing heterocyclic compound production method is for obtaining a compound represented by formula (2) through intramolecular cyclization of a compound represented by formula (1). X1 represents a hydrogen atom, a fluorin...  
WO/2024/089216A1
Compounds of formula (I) wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides.  
WO/2024/090485A1
The present invention provides a method for producing a fluorine-containing compound under relatively mild conditions by introducing a fluorine atom into a wide variety of oxygen-containing compounds having a ketone group, an aldehyde gr...  
WO/2024/085386A1
It has been identified that an alkynyl amino acid ester derivative preparation method using a photocatalytic reaction, according to the present invention, is simple and enables a linear, cyclic or chiral alkynyl amino acid ester derivati...  
WO/2024/085607A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2024/085208A1
This compound is a compound represented by formula (1). [In the formula, n represents an integer from 1-3. L1 represents a possibly branched, (n + 1)-valent linking group (but excluding chain saturated aliphatic hydrocarbon groups). ...  
WO/2024/085354A1
The present invention provides, in the present specification, a heterocyclic compound and an organic light-emitting device including same.  
WO/2024/084186A1
The presentation invention relates to compounds of formula (I) and pharmaceutical compositions thereof. The compounds may be used to treat an infection, such as a parasitic infection or a bacterial infection. In some embodiments, the com...  
WO/2024/079734A1
The invention relates to a method for preparing 4-alkoxy carbonyl-3 -aminothiophene of formula (I) or acid- addition salt thereof of formula (I)', which comprises reacting the corresponding 3 -oxotetrahydrothiophenes compound of formula ...  
WO/2024/080128A1
The present invention addresses the problem of providing an actinic ray-sensitive or radiation-sensitive resin composition from which a resist pattern having a small LWR can be formed. An actinic ray-sensitive or radiation-sensitive resi...  
WO/2024/078137A1
An organic electroluminescent device and an electronic apparatus. The organic electroluminescent device comprises a cathode, an anode, and an organic layer, the organic layer comprises an organic light-emitting layer, and the organic lig...  
WO/2024/081714A2
Disclosed herein are new inhibitors of GroEL/ES and HSP60/10 chaperonin systems that serve as new antibiotic candidates against a variety of infectious organisms. The identified compounds can selectively kill Escherichia coli, the ESKAPE...  
WO/2024/076117A1
The present invention is an organic compound used in an organic layer provided in an organic light-emitting element. In particular, when the organic compound is used in an electron blocking layer of an organic light-emitting element, it ...  
WO/2024/075537A1
The present invention addresses the problem of providing a reactive compound having excellent storage stability. The present invention relates to a reactive compound represented by formula (1). (In formula (1), Ar1 denotes an aromatic ...  
WO/2024/071281A1
The purpose of the present invention is to provide: a novel asymmetric fluorinated allyl compound that can be induced to various bioactive medium-sized molecules, and that has high optical purity; and a method for producing the same. Asy...  
WO/2024/067560A1
Disclosed in the present invention are a sulfonamide compound and the medical use thereof as a STING inhibitor, specifically, a compound as represented by formula (I) or a pharmaceutically acceptable salt or ester or solvate thereof, whi...  
WO/2024/071771A1
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.  
WO/2024/071770A1
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability and lifespan of an element; an organic electrical element using same; and an electronic device thereof.  
WO/2024/071250A1
This diamondoid compound is a new compound represented by general formula (1) [in the formula, ring A1 represents an aliphatic ring having two or more rings, R1 represents a hydrogen atom, an alkyl group, a cycloalkyl group, or an adaman...  
WO/2024/059951A1
This invention provides compound having a structure of Formulas I-VI. Uses of such compounds for treatment of various indications that would benefit from modulation of the androgen receptor, including prostate cancer. Also provided are m...  
WO/2024/059659A1
Provided herein are compounds of formula (I): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, Y1, Y2, X1, X2, X3, Q1, and Ra are as defined elsewhere herein. Also provid...  

Matches 1 - 50 out of 16,201